The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients

Completed

• Conditions: Coronary Artery Bypass Grafting; Heart Valve Diseases; Heart Diseases

• Registration Number: NCT00226265
• Lead Sponsor: Weill Medical College of Cornell University

Brief Summary

The purpose of this study is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

Detailed Description

The purpose of this study, is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

Study Timeline

• Study Start: 1999-01
• Study First Submitted: 2005-09-14
• Study First Submitted QC: 2005-09-22
• Study First Posted: 2005-09-26
• Primary Completion: 2006-12
• Study Completion: 2007-09
• Status Verified: 2017-02
• Last Update Submitted: 2017-02-17
• Last Update Posted: 2017-02-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Cardiac surgery patients who are between the ages of 18 and 100

• Are English speaking

• Able to give consent

• Undergoing cardiac surgery including (but not limited to):

  • Aortic valve replacement (AVR)
  • Mitral valve replacement (MVR)
  • Tricuspid valve replacement (TVR)
  • Coronary artery bypass graft (CABG).

Read More

Exclusion Criteria

• Non-cardiac surgery patients

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

The New York Presbyterian Hospital-Weill Medical Center; 🇺🇸 New York, New York, United States